Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AtriCure (ATRC) Shares Outstanding (2016 - 2025)

AtriCure (ATRC) has disclosed Shares Outstanding for 16 consecutive years, with $49.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.89% to $49.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.8 million through Dec 2025, up 1.89% year-over-year, with the annual reading at $49.8 million for FY2025, 1.89% up from the prior year.
  • Shares Outstanding for Q4 2025 was $49.8 million at AtriCure, roughly flat from $49.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $49.8 million in Q4 2025, with the low at $45.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $47.6 million, with a median of $47.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding rose 13.84% in 2021, then grew 1.11% in 2022.
  • Over 5 years, Shares Outstanding stood at $46.0 million in 2021, then rose by 1.19% to $46.6 million in 2022, then increased by 2.07% to $47.5 million in 2023, then rose by 2.83% to $48.9 million in 2024, then grew by 1.89% to $49.8 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $49.8 million, $49.7 million, and $49.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.